Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mature B-Cell Lymphoma And Leukemia Study III
NCT01046825Phase 3Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Sep 2010
- Primary completion
- Aug 2023
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Targeted Liposomes
- Countries
- 3
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection, prednisone, cyclophosphamide, pegylated liposomal doxorubicin, methotrexate in mature B-cell lymphoma, sponsored by St. Jude Children's Research Hospital. Started Sep 2010; status: active, not recruiting.
02
Drugs
vincristine sulfate liposome injectionprednisonecyclophosphamidepegylated liposomal doxorubicinmethotrexate
03
Conditions
mature B-cell lymphoma
Beyond the preview
Go deeper on NCT01046825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046825.